About 400 Mg Bevacizumab Injection
Experience the illustrious efficacy of 400 Mg Bevacizumab Injection, meticulously decorated in a lavish sterile glass vial. Approved for prescription-only use, this bargain monoclonal antibody targets VEGF for clinical effectiveness in metastatic colorectal cancer, lung cancer, renal cell carcinoma, and solid tumors. Promotion valid for hospital administration only: order today to benefit from a meticulously regulated single-use vial with barcode authentication. The neutral pH solution requires dilution prior to intravenous infusion. Safety precautions are vital-monitor for hypersensitivity reactions during use. Registered and proven, ensure proper storage between 2C to 8C. Shelf life is 24 months.
Application and Directions for Use
400 Mg Bevacizumab Injection is designed for intravenous infusion as part of anticancer therapy. The solution must be diluted with saline or another suitable IV fluid before administration, ensuring precise dosing for hospital use. As a prescription-only drug, it is administered by qualified healthcare professionals. Its commercial utility is primarily targeted at treating metastatic cancers, such as colorectal, lung, and renal cell carcinoma, with proven clinical efficacy.
Supply Ability and Export Information
Our supply ability for 400 Mg Bevacizumab Injection is robust, efficiently handling orders through reliable goods transport networks. With a competitive list price, we cater to diverse export markets, including major regions with stringent regulatory standards. FOB Port options are available to optimize logistics during shipment. As a distributor, exporter, supplier, and trader based in India, we prioritize quality goods and timely delivery to international buyers.
FAQ's of 400 Mg Bevacizumab Injection:
Q: How should 400 Mg Bevacizumab Injection be administered to patients?
A: The injection must be diluted with saline or suitable intravenous fluids before administration and is delivered via intravenous infusion by healthcare professionals in hospital settings.
Q: What are the primary indications for using Bevacizumab Injection?
A: This medication is clinically indicated for treating metastatic cancers such as colorectal cancer, lung cancer, renal cell carcinoma, and other solid tumors.
Q: When should dilution of the Bevacizumab Injection occur?
A: Dilution should always occur prior to infusion, using sterile saline or a suitable IV fluid, and must be prepared by trained medical staff.
Q: Where is 400 Mg Bevacizumab Injection typically used?
A: It is typically used in hospitals due to strict monitoring requirements and safety precautions necessary for patient care during anticancer treatment.
Q: What safety precautions must be followed during administration?
A: Patient monitoring for hypersensitivity reactions is essential. The medication is contraindicated in pregnancy and for individuals with hypersensitivity to its ingredients.
Q: How is the product packed and stored to maintain quality?
A: The injection comes in a single-use sterile glass vial with barcode identification, and must be stored between 2C to 8C, avoiding freezing to ensure product integrity.